These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33155341)

  • 41. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
    Majed SO; Mustafa SA
    BMC Cancer; 2021 Apr; 21(1):473. PubMed ID: 33910530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.
    Church C; Pulliam T; Longino N; Park SY; Smythe KS; Makarov V; Riaz N; Jing L; Amezquita R; Campbell JS; Gottardo R; Pierce RH; Choi J; Chan TA; Koelle DM; Nghiem P
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36252564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity.
    Wang Q; Shashikant CS; Jensen M; Altman NS; Girirajan S
    Sci Rep; 2017 Apr; 7(1):885. PubMed ID: 28408746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted variant detection using unaligned RNA-Seq reads.
    Audemard EO; Gendron P; Feghaly A; Lavallée VP; Hébert J; Sauvageau G; Lemieux S
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31427380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction.
    Lao Y; Wang Y; Yang J; Liu T; Ma Y; Luo Y; Sun Y; Li K; Zhao X; Niu X; Xi Y; Zhong C
    Front Oncol; 2022; 12():941868. PubMed ID: 36439494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A benchmark of hemoglobin blocking during library preparation for mRNA-Sequencing of human blood samples.
    Uellendahl-Werth F; Wolfien M; Franke A; Wolkenhauer O; Ellinghaus D
    Sci Rep; 2020 Mar; 10(1):5630. PubMed ID: 32221409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma.
    Ramirez CA; Becker-Hapak M; Singhal K; Russler-Germain DA; Frenkel F; Barnell EK; McClain E; Desai S; Schappe T; Onyeador OC; Kudryashova O; Belousov V; Bagaev A; Ocheredko E; Kiwala S; Hundal J; Skidmore ZL; Watkins MP; Mooney TB; Walker J; Krysiak K; Gomez F; Fronick CC; Fulton RS; Schreiber RD; Mehta-Shah N; Cashen AF; Kahl BS; Ataullakhanov R; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2024 May; ():. PubMed ID: 38713894
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
    Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.
    Zhou C; Wei Z; Zhang Z; Zhang B; Zhu C; Chen K; Chuai G; Qu S; Xie L; Gao Y; Liu Q
    Genome Med; 2019 Oct; 11(1):67. PubMed ID: 31666118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy.
    Yang X; Fan J; Wu Y; Ma Z; Huang J; Zhang Y; Zhou Z; Mo F; Liu X; Yuan H; Xu Y; Pan L; Chen S
    Nanomedicine; 2021 Oct; 37():102443. PubMed ID: 34303839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
    Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.
    Dufresne A; Attignon V; Ferrari A; Tonon L; Boyault S; Tabone-Eglinger S; Cassier P; Trédan O; Corradini N; Vinceneux A; Swalduz A; Viari A; Chabaud S; Pérol D; Blay JY; Saintigny P
    Cancer Med; 2024 Apr; 13(7):e7115. PubMed ID: 38553950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of differential gene expression by multiplexed targeted resequencing of cDNA.
    Arts P; van der Raadt J; van Gestel SHC; Steehouwer M; Shendure J; Hoischen A; Albers CA
    Nat Commun; 2017 May; 8():15190. PubMed ID: 28474677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison between whole transcript and 3' RNA sequencing methods using Kapa and Lexogen library preparation methods.
    Ma F; Fuqua BK; Hasin Y; Yukhtman C; Vulpe CD; Lusis AJ; Pellegrini M
    BMC Genomics; 2019 Jan; 20(1):9. PubMed ID: 30616562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measuring Tumor Mutational Burden Using Whole-Exome Sequencing.
    Vilimas T
    Methods Mol Biol; 2020; 2055():63-91. PubMed ID: 31502147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast Cancer Neoantigens Can Induce CD8
    Zhang X; Kim S; Hundal J; Herndon JM; Li S; Petti AA; Soysal SD; Li L; McLellan MD; Hoog J; Primeau T; Myers N; Vickery TL; Sturmoski M; Hagemann IS; Miller CA; Ellis MJ; Mardis ER; Hansen T; Fleming TP; Goedegebuure SP; Gillanders WE
    Cancer Immunol Res; 2017 Jul; 5(7):516-523. PubMed ID: 28619968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing.
    Pedersen CB; Nielsen FC; Rossing M; Olsen LR
    Mol Oncol; 2018 Dec; 12(12):2136-2146. PubMed ID: 30289602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype.
    Linxweiler M; Kuo F; Katabi N; Lee M; Nadeem Z; Dalin MG; Makarov V; Chowell D; Dogan S; Ganly I; Hakimi AA; Wong RJ; Riaz N; Ho AL; Chan TA; Morris LGT
    Clin Cancer Res; 2020 Jun; 26(12):2859-2870. PubMed ID: 32060100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
    Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.